Deals in Depth: February 2011
Executive Summary
Astellas added Phase III tivozanib to its pipeline in a $700mm deal with Aveo. Diagnostics and analytical testing companies fared well in M&A, including Danaher's $6.8 billion acquisition of Beckman Coulter. Biopharma financing jumped 7% to $1.9 billion, and device companies also raised more money than last month - $367 million vs. $189 million.
You may also be interested in...
J&J Has A Plan B If Gamechanger Single Dose Vaccine Disappoints
If J&J’s gamble on a single dose pays off, it could rapidly advance the fight against SARS-CoV2 – but a second study will provide a safety net.
Woodcock To Be Acting US FDA Commissioner; Sharfstein Tops Biden's List Of Candidates For Post
Agency has been prepping Woodcock for the temporary task but what will happen to her role on Operation Warp Speed remains unclear. The move should give Biden team cushion to confirm a permanent leader of whom a top contender is former senior FDA staffer Joshua Sharfstein, a proponent of drug reforms that may irk manufacturers.
Health And Wellness Trademark Review 12 January, 2021
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Need a specific report? 1000+ reports available
Buy Reports